ANDREW: A Multicenter, Prospective, Observational Study in Patients with Type 2 Diabetes on Persistent Treatment with Dulaglutide

Introduction Dulaglutide, a long-acting glucagon-like peptide-1 receptor agonist (GLP-1RA), became available in Italy in April 2016. The aim of ANDREW ( A ctive N otes on D ulaglutide in the RE al W orld), a multicenter, prospective, observational study, was to evaluate glycemic control and weight (...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes therapy 2020-11, Vol.11 (11), p.2677-2690
Hauptverfasser:	Bossi, Antonio C., De Mori, Valentina, Scaranna, Cristiana, Veronesi, Giovanni, Lepore, Giuseppe
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiology Clinical outcomes Clinical trials Diabetes Drug therapy Endocrinology GLP-1 receptor agonists Internal Medicine Medicine Medicine & Public Health Observational studies Original Research Patient satisfaction Peptides
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!